Brillio · 3 days ago
Domain Expert
Brillio is one of the fastest growing digital technology service providers, renowned for its world-class professionals. They are seeking an HCP Marketing Architect to design and lead the end-to-end strategy and digital ecosystem for healthcare professional engagement, blending marketing, technology, and clinical understanding.
AnalyticsArtificial Intelligence (AI)Big DataCloud ComputingConsultingEnterprise ApplicationsMachine LearningMobile
Responsibilities
Develop the overall architecture for HCP engagement across digital, CRM, content, and data platforms
Translate brand and medical strategy into actionable omnichannel roadmaps
Design modular content frameworks and personalized HCP journeys
Partner with Brand, Medical, Regulatory, Field, and Digital teams to align strategy and execution
Define KPIs, data flows, and measurement standards, for HCP engagement and channel effectiveness
Lead platform integration efforts (Veeva, MA tools, CMS, analytics)
Drive innovation in personalization, content automation, and next‑best‑action and omnichannel models
Qualification
Required
10+ years in pharma/biotech HCP marketing, digital strategy, or CRM/digital architecture
Strong understanding of customer journeys, HCP behavior, and pharma regulations
Experience with Veeva Ecosystems (CRM and Vault), marketing automation, or enterprise digital platforms
Ability to convert business needs into scalable systems, workflows, and data models
Bachelor's required
Preferred
advanced degree preferred
Company
Brillio
Brillio is a technology consulting and technology services company focused on the implementation of digital technologies.
H1B Sponsorship
Brillio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (258)
2024 (240)
2023 (281)
2022 (314)
2021 (196)
2020 (406)
Funding
Current Stage
Late StageTotal Funding
unknownKey Investors
The Orogen Group
2023-09-05Private Equity
2019-01-14Acquired
Recent News
Canada NewsWire
2026-01-14
Financial Express
2025-03-21
Company data provided by crunchbase